cardiac arrhythmia; pulse rate increased; besides, a constant temperature between 37.5 and 38; tachycardia; inappropriate schedule of vaccine administered/ first dose on 18may2021 and second dose on 29jun2021; this is a spontaneous report received from contactable reporter(s) (consumer or other non hcp and physician) from the regulatory authority-web. regulatory number: at-basgages-2021-064705 (ra). a 39 year-old female patient received bnt162b2 (comirnaty), administration date 29jun2021 (lot number: fd6840) as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: comirnaty (dose 1), administration date: 18may2021, for covid-19 immunization. the following information was reported: inappropriate schedule of product administration (medically significant) with onset 29jun2021, outcome "unknown", described as "inappropriate schedule of vaccine administered/ first dose on 18may2021 and second dose on 29jun2021"; arrhythmia (medically significant) with onset jul2021, outcome "recovered", described as "cardiac arrhythmia"; heart rate increased (medically significant) with onset jul2021, outcome "recovered", described as "pulse rate increased"; body temperature abnormal (medically significant) with onset jul2021, outcome "recovered", described as "besides, a constant temperature between 37.5 and 38"; tachycardia (medically significant) with onset jul2021, outcome "recovered", described as "tachycardia". the patient underwent the following laboratory tests and procedures: body temperature: between 37.5 and 38; heart rate: increased. no follow-up attempts are possible. no further information is expected

test name: body temperature; result unstructured data: test result:between 37.5 and 38 centigrade; test name: heart rate; result unstructured data: test result:increased

na

na